Skip to main content
Clinical Trials/RBR-77sqd4z
RBR-77sqd4z
Not yet recruiting
未知

Study with cancer patients followed at the Pain Therapy and Palliative Care Service of Fundação Cecon: an analysis of quality of life and the impact of a Meditation intervention with Immersive Virtual Reality for pain relief

Fundação Centro de Controle de Oncologia do Estado do Amazonas - FCECO0 sitesApril 15, 2024

Overview

Phase
未知
Intervention
Not specified
Conditions
Quality of life
Sponsor
Fundação Centro de Controle de Oncologia do Estado do Amazonas - FCECO
Status
Not yet recruiting
Last Updated
2 years ago

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
April 15, 2024
End Date
August 25, 2025
Last Updated
2 years ago
Study Type
Intervention

Investigators

Sponsor
Fundação Centro de Controle de Oncologia do Estado do Amazonas - FCECO

Eligibility Criteria

Inclusion Criteria

  • Be monitored at the Pain Therapy and Palliative Care Service (STDCP) to control symptoms arising from any type of neoplasia at any stage; a diagnosis of chronic pain recorded in the medical record; both genders, male and female; be between 18 and 75 years old on the date of the first collection; able to understand Portuguese (read and write); normal vision and hearing; have an Android cell phone; able to perform movements with the head and with sufficient motor control to perform body movements; agree to participate in the study and sign the Free and Informed Consent Form (ICF)

Exclusion Criteria

  • Patients of the indigenous race, due to cultural, linguistic peculiarities and legislation special; patients with records of serious psychiatric illnesses in the medical record from Diagnostic and Statistical Manual of Mental Disorders (DSM\-5\), schizophrenia, schizotypal disorders, delusional disorders, borderline and dementia; impairment of the ability to understand or communicate based on the researcher's assessment; report of discomfort with the use of Immersive Virtual Reality; progression of the disease with the limitation of maintaining the proposed regular outpatient return; patients with brain tumors, brain metastases, or past history of seizures

Outcomes

Primary Outcomes

Not specified

Similar Trials